The U.S. IPO market is expected to see a blowout 2025, fueled by the return of business-friendly Donald Trump to the White ...

The U.S. IPO market is expected to see a blowout 2025, fueled by the return of business-friendly Donald Trump to the White ...

According to Nasdaq’s data, the U.S. saw 179 non-SPAC IPOs in 2024 – the most since 2021, and a 40% increase over 2023 (127). By value raised (ex SPACs), it was an even better year, with value raised ...

"Beta Bionics joins IPO uptick, aims to raise $114.4m in Nasdaq listing" was originally created and published by Medical ...

Underwriters have a 30-day option to purchase extra 1.13 million shares from present owners at IPO price. Beta Bionics will ...

The carve-out listing is expected to be completed by ... We look forward to welcoming more Nasdaq IPOs in 2025, capitalizing on emerging opportunities in their respective markets,” said Dato ...

In 2024, IPO performance was promising, with most major listings ending the year above their debut prices. Experts, including Eddie Molloy of Morgan Stanley, expect significant activity in ...

The buzz around biotech IPOs is continuing through January, with clinical-stage metabolic company Aardvark Therapeutics ...

It was the biggest initial public offering (IPO) in history at the time ... Consider when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation ...

Klarna has retained Goldman Sachs, JPMorgan and Morgan Stanley to lead the listing. The digital payments company is one of the most anticipated 2025 IPOs. While no specific date has been announced ...

Obesity drug developer Aardvark Therapeutics (AARD) has filed for a $100M initial public offering. Aardvark (AARD) didn't ...